ArticleJournal of thoracic disease2026
Diagnostic accuracy of combined TCF-21 protein expression and computed tomography morphological features for predicting microvascular invasion in early-stage non-small cell lung cancer.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Preoperative identification of microvascular invasion (MVI) in clinically early-stage non-small cell lung cancer (NSCLC) remains difficult because microscopic vascular spread cannot be reliably inferred from tumor size or nonspecific computed tomography (CT) features alone. This diagnostic accuracy study aimed to evaluate whether biopsy-derived transcription factor 21 (TCF-21) protein expression combined with a rigorously defined CT vessel convergence sign could predict pathological MVI. Methods: A retrospective diagnostic accuracy cohort of 50 patients with pathologically confirmed stage I NSCLC who underwent curative-intent surgical resection at the Affiliated Hospital of Hebei University of Engineering between March 2023 and August 2023 was enrolled. Patients were categorized into MVI-positive (n=15) and MVI-negative (n=35) groups according to the postoperative pathological reference standard. Preoperative chest CT scans and TCF-21 protein expression levels quantified by Western blot from preoperative biopsy specimens were evaluated. CT morphological features included tumor size, spiculation, lobulation, and vessel convergence sign, which was strictly defined to exclude volume-loss atelectasis or mechanical vascular displacement. Logistic regression and receiver operating characteristic (ROC) curve analyses were used to develop and evaluate the exploratory prediction model. Results: The cohort predominantly consisted of men (62.0%), and the mean age was 55.9 years. TCF-21 protein expression was significantly lower in the MVI-positive group than in the MVI-negative group (0.42±0.11 Conclusions: Decreased TCF-21 protein expression and CT vessel convergence were associated with pathological MVI in early-stage NSCLC. These preliminary findings suggest that an integrated molecular-radiological approach may support preoperative risk stratification after validation in larger external cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.